Mycoplasma Testing Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Market Overview

The mycoplasma testing market is estimated to register a healthy CAGR over the forecast period. Factors, such as high spending in R&D activities by biopharmaceutical companies, increased government initiatives and funding in research activities, technological advancements, increasing demand for fast, accurate, and affordable testing, and the increasing cell culture contamination, are further driving the market for mycoplasma testing. However, there are certain stringent government regulations across several developed and emerging countries and a high degree of consolidation for new entrants, which are among the major hindrances in the growth of the mycoplasma testing market.

Scope of the Report

The term “mycoplasma” refers to a class of bacteria that is commonly present in cell culture. More correctly known as mollicutes, these bacteria lack a cell wall, making them resistant to commonly used antibiotics, such as penicillin. Mycoplasma is easily spread through droplets during cell culture and can survive in dried form for months. Mycoplasma contamination is difficult to see with a microscope and requires specific testing, to be detected. Contamination can have a profound impact on experimental work. Depending on the species present, mycoplasma organisms can affect cell growth, metabolism, tumourigenicity, and response to chemotherapy.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Polymerase Chain Reaction (PCR) Holds Significant Market Share

Polymerase Chain Reaction (PCR) is a technique that is used to amplify target DNA and generate thousands to millions of copies of a particular DNA segment. PCR techniques are used in clinical and research laboratories for a broad variety of applications, which include clinical diagnosis, criminal forensics, and biomedical research. The major factors attributed to the growth of the polymerase chain reaction segment include the increasing application in clinical diagnostics, rising demand for personalized and precision medicine, and technological advancements and applications in drug development. 

For instance, in July 2018, ATCC, the premier global biological materials resource and standards organization and the leading supplier of authenticated cells and advanced cell models, launched its new PCR-based service to detect mycoplasma contamination in cell cultures. ATCC has long recognized the growing challenges among the scientific community for adventitious agent contamination included in cell-based research. Hence, the company introduced this product line to support the authentication of cell lines used in basic and translational research, and it complements the STR profiling service.

To understand key trends, Download Sample Report